Skip to main content

Table 3 Proportion of patients with reduction in total fibroid volume at 6 months

From: The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China

Reduction in total fibroid volume (%)

Peking (N = 58)

Xi’an (N = 49)

Overall (N = 107)

≥10

0.90 (0.79, 0.96)

0.96 (0.86, 1.00)

0.93 (0.86, 0.97)

≥20

0.89 (0.77, 0.96)

0.87 (0.74, 0.95)

0.88 (0.80, 0.94)

≥30

0.76 (0.62, 0.87)

0.74 (0.59, 0.86)

0.75 (0.65, 0.83)

≥40

0.69 (0.54, 0.80)

0.52 (0.37, 0.67)

0.61 (0.51, 0.71)

≥50

0.46 (0.33, 0.60)

0.30 (0.18, 0.46)

0.39 (0.29, 0.49)